Phase I Safety and Immunogenicity Study of VAX102 [Flagellin.HuM2e] Influenza Vaccine in Healthy Adults

Clinical trial NCT00603811 · COMPLETED

Trial details

NCT number: NCT00603811
Sponsor: VaxInnate Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza Infection

Start date: 2007-09-01
Primary completion: 2008-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.